Alzheimer's Disease: Preparing for the “Silent Epidemic” in Europe
According to the World Health Organization, the number of people aged 60 years and older is set to increase from 1 billion in 2019 to 2.1 billion by 2050. This is a key driver behind the growing prevalence of Alzheimer’s disease and its increasingly heavy burden on health systems.
New care options for Alzheimer’s disease under development hold great potential. However, public awareness is severely lacking, as is the capacity of many health systems for early detection and diagnosis. As prevalence continues to rise and the treatment landscape evolves, healthcare stakeholders will need to engage with patients sooner and with greater urgency to drive better outcomes.
This webinar, hosted by the Financial Times in partnership with Biogen and eu40, will consider fundamental changes needed to increase awareness of Alzheimer’s disease, improve diagnosis rates and enhance options for care.
Key themes
Health System Readiness
What are the key challenges in healthcare readiness for Alzheimer’s disease and how do they vary across Europe? What can be done to improve health infrastructure?
Public Awareness
How can public awareness of Alzheimer’s disease be increased in a way that reduces stigma and leads to earlier intervention?
Leadership
Where is the political leadership on Alzheimer’s disease? How can governments work with other stakeholders to drive progress?
Why Attend?
Understand
The big picture, not just the individual strands of the business you work in
Connect
And build relationships with some of the biggest names in your industry
Discover
New approaches and strategies to help win market share
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice